Product Manual
Page 1 of 15
Sofia Strep A FIA
INTENDED USE
The Sofia Strep A FIA employs immunofluorescence technology to detect Group A Streptococcal antigens from throat
swabs of symptomatic patients. All negative test results should be confirmed by bacterial culture because negative results
do not preclude Group A Strep infection and should not be used as the sole basis for treatment. The test is intended for
professional and laboratory use as an aid in the diagnosis of Group A Streptococcal infection.
SUMMARY AND EXPLANATION
Group A Streptococcus is one of the most common causes of acute upper respiratory tract infection. Early diagnosis
and treatment of Group A Streptococcal pharyngitis has been shown to reduce the severity of symptoms and serious
complications such as rheumatic fever and glomerulonephritis.
1, 2
Conventional procedures for identification of Group A
Streptococcus from throat swabs involve the culture, isolation, and subsequent identification of viable pathogen at 24 to
48 hours or longer for results.
3, 4
PRINCIPLE OF THE TEST
The Sofia Strep A FIA employs immunofluorescence technology that is used with the Sofia analyzer (Sofia) to detect
Group A Streptococcal antigen.
The Sofia Strep A FIA involves the extraction of the antigenic components of the Group A Streptococcus (GAS) bacteria.
The patient’s Swab specimen is placed in the Reagent Tube containing the Reagent Solution, during which time the
bacterial antigens are extracted, making them more accessible to the specific antibodies. An aliquot of the extracted
specimen is dispensed into the Cassette sample well. From the sample well, the specimen migrates through a test strip
containing various unique chemical environments. If Group A Streptococcal antigens are present, they will be bound
by antibodies coupled to fluorescent microparticles that migrate through the test strip. The fluorescent microparticles
containing bound antigen will be captured by antibodies at a defined location on the test strip where they are detected
by Sofia. If antigens are not present, the fluorescent microparticles will not be trapped by the capture antibodies nor
detected by Sofia.
Note: Depending upon the user’s choice, the Cassette, now containing the specimen, is either placed directly inside Sofia
for automatically timed development (WALK AWAY Mode) or placed on the counter or bench top for a manually timed
development and then placed into Sofia (READ NOW Mode).
Sofia scans, measures, and interprets the immunofluorescent signal, using on-board method-specific algorithms. Sofia will
then report the test results to the user (Positive, Negative, or Invalid) on its display screen, and it can print out the results via
an integrated printer or transmit the results via an LIS connection.
FOR USE WITH SOFIA ONLY